Dobson|DaVanzo

Sandra Agik, M.A.

Associate
703.722.8020

Sandra Agik, M.A., an Associate at Dobson | DaVanzo, brings a broad range of experience in conducting clinical research, epidemiological analyses, and survey design to the firm.

Prior to Dobson | DaVanzo, Ms. Agik worked as a Senior Analyst at the Advisory Board where she conducted qualitative and quantitative best practice research to generate insights for Healthcare Executives across the nation. Ms. Agik served on the Post-Acute Care Research Collaborative where she supported numerous analyses of Medicare FFS claims data to generate business strategy insights concerning post-acute care clinical pathways and benchmark performance on key quality metrics. Ms. Agik also served on the Health Plan Advisory Council where she led the firm’s project guiding Medicare Advantage Health Plans in launching the newly allowed supplemental benefits.

As an undergraduate Ms. Agik served as a research assistant in Dr. Timothy Niewold’s genetics lab and investigated the genetic association between UBE2L3 gene and Systematic Lupus Erythematous (SLE) in African American patients. Ms. Agik investigated the risk of UBE2L3 gene in Systematic Lupus Erythematosus in African American patients using SNP genotyping methods on a patient cohort of 252 and matched controls. She published results in the Journal of Rheumatology. (March 2012)

Post-baccalaureate, Ms. Agik continued to conduct clinical research as a Clinical Research Associate at the Center for Clinical Cancer Genetics at the University of Chicago, where she coordinated and managed several interventional cancer research studies. Ms. Agik led the start-up of a multi-site study to return research genetic panel testing results by telephone/video conferencing to women at increased risk for breast cancer who had previously donated samples for research purposes. Ms. Agik also monitored and managed two federally funded clinical trials for subjects diagnosed with hereditary breast and ovarian cancer syndrome and those at high risk of developing breast cancer with study sites in Nigeria, Uganda and the U.S.

During her graduate program at Brown University Ms. Agik coordinated and managed several epidemiological studies. At the Rhode Island Hospital’s Emergency Department, Ms. Agik coordinated a multi-site clinical study on HIV/AIDS literacy and monitored study data for completeness, accuracy and consistency. Ms. Agik also conducted phone interviews to assess participant satisfaction with study-provided HIV-self test kits. During a summer internship at the Dana Farber Cancer Institute, Ms. Agik planned and conducted a quality improvement research project to streamline the abstraction of clinical and treatment data from hospital electronic medical records to annotate longitudinal outcomes of patients.

At Dobson | DaVanzo, Ms. Agik is currently supporting research, and providing analytical assistance on planned and ad hoc analyses to assess the impact of Patient-Driven Groupings Model (PDGM) on Home Health using CY2020 Medicare Home Health Services claims data. She is also working on summarizing findings in reports and presentations, as well as conducting comprehensive literature reviews and assisting with quantitative data collection and analysis.

Ms. Agik holds a Bachelor of Arts degree in Biological Sciences from the University of Chicago and a Master of Science degree in Epidemiology from Brown University. Ms. Agik is a recipient of numerous honors and awards including the Jeff Metcalf Fellowship Summer Grant ( 2012-2013), the Aga Khan Foundation International Scholarship (2015-2017), and the Minority Training Program in Cancer Control Research Summer Institute Fellowship (2016).

Go Back